Literature DB >> 6271810

Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes.

J I Ravdin, R L Guerrant.   

Abstract

The enteric pathogen, Entamoeba histolytica, appears to cause disease by adhering to and then destroying mucosal barriers. Using an in vitro method of studying the interaction of E. histolytica with target cells (Chinese hamster ovary [CHO] and human erythrocytes [RBC]), we examined the mechanism of amebic adherence and its role in lysis of target cells. Killing and phagocytosis of target cells by amebas ceases at 4 degrees C, allowing observation of adherence. Amebas adhere to CHO cells at 4 degrees C, 78.9% formed rosettes (amebas with >/=3 adherent CHO cells each) at 2 h. At 37 degrees C, cytochalasins B and D inhibit adherence of amebas to CHO cells (P < 0.0005). Amebas adhere to and kill CHO cells in media with <0.1 muM calcium and magnesium plus 10 mM EDTA, indicating that divalent cations are not required in the medium. Adherence of amebas to human RBC was not ABO blood group specific and showed greater adherence to human than bovine or sheep RBC (P < 0.005). Neither Fc nor complement receptors were found on amebas by standard rosette studies. The amebic adherence receptor is not trypsin (0.125%) sensitive nor inhibited by trypan blue (1 mM). N-acetyl-d-galactosamine (GALNAc) inhibited the adherence of amebas to CHO cells and human RBC (0.1 g/100 ml or 4.5 mM GALNAc, P < 0.005) by binding to a receptor on the amebic surface. GALNAc abolishes amebic cytolysis of target CHO cells (determined by (111)Indium oxine release from CHO cells, P < 0.001) but not amebic phagocytosis of CHO cells. By suspending ameba-CHO cells rosettes in dextran, we found that GALNAc (1%) reversibly inhibits amebic adherence (P < 0.0005) and that cytochalasins decrease amebic killing of adherent CHO cells (P < 0.025). These findings indicate that the adherence of E. histolytica to target cells requires microfilament function, is via a specific amebic receptor that has affinity for GALNAc, and is required to lyse cells. Inhibition of the adherence of E. histolytica may alter the pathogenicity of this organism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271810      PMCID: PMC370926          DOI: 10.1172/jci110377

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  THE TOXIC EFFECT OF ENTAMOEBA HISTOLYTICA ON LEUCOCYTES.

Authors:  R JARUMILINTA; F KRADOLFER
Journal:  Ann Trop Med Parasitol       Date:  1964-09

Review 2.  Surface components and cell recognition.

Authors:  W Frazier; L Glaser
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

3.  Entamoeba histolytica "toxin": fetuin neutralizable and lectin-like.

Authors:  C F Mattern; D B Keister; P C Natovitz
Journal:  Am J Trop Med Hyg       Date:  1980-01       Impact factor: 2.345

4.  Interaction between Entamoeba histolytica and human polymorphonuclear neutrophils.

Authors:  R L Guerrant; J Brush; J I Ravdin; J A Sullivan; G L Mandell
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

5.  Lectin activity in Entamoeba histolytica trophozoites.

Authors:  D Kobiler; D Mirelman
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

6.  Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG.

Authors:  H D Kay; R Fagnani; G D Bonnard
Journal:  Int J Cancer       Date:  1979-08       Impact factor: 7.396

7.  Cytopathogenic mechanisms of Entamoeba histolytica.

Authors:  J I Ravdin; B Y Croft; R L Guerrant
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

8.  Attachment and short-term maintenance of motility and viability of Entamoeba histolytica in a defined medium.

Authors:  F D Gillin; L S Diamond
Journal:  J Protozool       Date:  1980-05

9.  Lysosomal enzyme inhibition by trypan blue: a theory of teratogenesis.

Authors:  F Beck; J B Lloyd; A Griffiths
Journal:  Science       Date:  1967-09-08       Impact factor: 47.728

10.  Surface redistribution and release of antibody-induced caps in entamoebae.

Authors:  J Calderón; M de Lourdes Muñoz; H M Acosta
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  128 in total

1.  The cysteine-rich region of the Entamoeba histolytica adherence lectin (170-kilodalton subunit) is sufficient for high-affinity Gal/GalNAc-specific binding in vitro.

Authors:  D R Pillai; P S Wan; Y C Yau; J I Ravdin; K C Kain
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Evidence that hyaluronidase is not involved in tissue invasion of the protozoan parasite Entamoeba histolytica.

Authors:  R Nickel; R Stern; M Leippe
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  Entamoeba histolytica expressing a dominant negative N-truncated light subunit of its gal-lectin are less virulent.

Authors:  Uriel Katz; Serge Ankri; Tamara Stolarsky; Yael Nuchamowitz; David Mirelman
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

4.  Down regulation of Entamoeba histolytica virulence by monoxenic cultivation with Escherichia coli O55 is related to a decrease in expression of the light (35-kilodalton) subunit of the Gal/GalNAc lectin.

Authors:  F Padilla-Vaca; S Ankri; R Bracha; L A Koole; D Mirelman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Sequence of a cysteine-rich galactose-specific lectin of Entamoeba histolytica.

Authors:  B J Mann; B E Torian; T S Vedvick; W A Petri
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 6.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

7.  Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.

Authors:  Mayuresh M Abhyankar; Zannatun Noor; Mark A Tomai; James Elvecrog; Christopher B Fox; William A Petri
Journal:  Vaccine       Date:  2017-01-12       Impact factor: 3.641

8.  Inhibition by sugars of Candida albicans adherence to human buccal mucosal cells and corneocytes in vitro.

Authors:  C Collins-Lech; J H Kalbfleisch; T R Franson; P G Sohnle
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage.

Authors:  R A Salata; R D Pearson; J I Ravdin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Contact-dependent transfer of the galactose-specific lectin of Entamoeba histolytica to the lateral surface of enterocytes in culture.

Authors:  A Leroy; G De Bruyne; M Mareel; C Nokkaew; G Bailey; H Nelis
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.